|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
152,980,000 |
Market
Cap: |
2.47(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$12.12 - $24.64 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Certara is a holding company. Through its subsidiaries, Co. delivers software products and technology-enabled services to customers to realize the benefits of biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions and market access. Co.'s End-to-End Platform provides software and technology-enabled services. Co. deploys its software to customers on public and private cloud networks, on-premises, and in data centers. Co.'s technology-enabled, biosimulation services help customers who do not have staff capability or availability to gain the benefits of biosimulation. Co. also provides related, technology-enabled services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
50,000 |
Total Buy Value |
$0 |
$0 |
$79,058 |
$821,458 |
Total People Bought |
0 |
0 |
1 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
4 |
Total Shares Sold |
31,427 |
37,427 |
112,755 |
38,359,838 |
Total Sell Value |
$550,001 |
$658,001 |
$1,921,662 |
$597,865,261 |
Total People Sold |
2 |
2 |
3 |
6 |
Total Sell Transactions |
5 |
6 |
9 |
23 |
End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith Patrick F |
PRESIDENT, DRUG DEV SOLUTIONS |
|
2024-04-02 |
4 |
AS |
$16.75 |
$243,161 |
D/D |
(14,427) |
50,091 |
|
-6% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-04-01 |
4 |
AS |
$18.00 |
$54,000 |
D/D |
(3,000) |
173,524 |
|
-12% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-04-01 |
4 |
D |
$17.88 |
$111,643 |
D/D |
(6,244) |
176,524 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,295 |
178,800 |
|
- |
|
Pedersen Leif E |
PRESIDENT, CHIEF COMMERCAL OFF |
|
2024-04-01 |
4 |
D |
$17.88 |
$106,404 |
D/D |
(5,951) |
150,928 |
|
- |
|
Pedersen Leif E |
PRESIDENT, CHIEF COMMERCAL OFF |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,498 |
152,840 |
|
- |
|
Aspbury Robert |
PRESIDENT; SCIENTIFIC SOFTWARE |
|
2024-04-01 |
4 |
D |
$17.88 |
$189,975 |
D/D |
(10,625) |
290,176 |
|
- |
|
Aspbury Robert |
PRESIDENT; SCIENTIFIC SOFTWARE |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,498 |
293,867 |
|
- |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2024-04-01 |
4 |
D |
$17.88 |
$46,095 |
D/D |
(2,578) |
24,358 |
|
- |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,219 |
25,684 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-04-01 |
4 |
D |
$17.88 |
$762,207 |
D/D |
(42,629) |
2,249,154 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,799 |
2,263,269 |
|
- |
|
Gallagher John E |
CHIEF FINANCIAL OFFICER |
|
2024-04-01 |
4 |
D |
$17.88 |
$162,297 |
D/D |
(9,077) |
18,218 |
|
- |
|
Gallagher John E |
CHIEF FINANCIAL OFFICER |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,295 |
22,545 |
|
- |
|
Smith Patrick F |
PRESIDENT, DRUG DEV SOLUTIONS |
|
2024-04-01 |
4 |
D |
$17.88 |
$124,355 |
D/D |
(6,955) |
64,518 |
|
- |
|
Smith Patrick F |
PRESIDENT, DRUG DEV SOLUTIONS |
|
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,498 |
67,208 |
|
- |
|
Pedersen Leif E |
PRESIDENT, CHIEF COMMERCAL OFF |
|
2024-03-05 |
4 |
D |
$18.88 |
$76,464 |
D/D |
(4,050) |
140,381 |
|
- |
|
Pedersen Leif E |
PRESIDENT, CHIEF COMMERCAL OFF |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,548 |
144,431 |
|
- |
|
Aspbury Robert |
PRESIDENT; SCIENTIFIC SOFTWARE |
|
2024-03-05 |
4 |
D |
$18.88 |
$138,032 |
D/D |
(7,311) |
284,303 |
|
- |
|
Aspbury Robert |
PRESIDENT; SCIENTIFIC SOFTWARE |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,549 |
285,992 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-03-05 |
4 |
D |
$18.88 |
$331,476 |
D/D |
(17,557) |
2,221,984 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
59,799 |
2,239,541 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-03-05 |
4 |
D |
$18.88 |
$69,101 |
D/D |
(3,660) |
169,473 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,765 |
173,133 |
|
- |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2024-03-05 |
4 |
D |
$18.88 |
$44,802 |
D/D |
(2,373) |
18,717 |
|
- |
|
187 Records found
|
|
Page 1 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|